產(chǎn)品目錄

規(guī)格	5mg 10mg 50mg 100mg
CAS	1001409-50-2
別名
化學(xué)名	1-[(3,4-difluorophenyl)methyl]-2-oxo-N-[(1R)-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]-1-phenylethyl]pyridine-3-carboxamide
分子式	C28H22F2N4O4
分子量	516.5
溶解度	Soluble in DMSO
儲(chǔ)存條件	Store at -20°C
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述：

PDK1 inhibitor is an potent and selective inhibitor of PDK1 with potential as anticancer agent. GSK 2334470,a inhibitor of PDK1, has IC50 value of 0.00251μM and CHEMBL1172241 with IC50 value of 0.085μM. [1]

PDPK1 stands for 3-phosphoinositide-dependent protein kinase 1, which is crucial for the activation of AKT/PKB and many other AGC kinases including PKC, S6K, SGK. [2]An important role for PDPK1 is in the signalling pathways activated by several growth factors and hormones including insulin signaling. PDPK1 functions downstream of PI3K through PDPK1's interaction with membrane phospholipids.[3]PI3K indirectly regulates PDPK1 by phosphorylating phosphatidylinositols which in turn generates phosphatidylinositol (3,4)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate. [4]However, PDPK1 is believed to be constitutively active and does not always require phosphatidylinositols for its activities. Phosphatidylinositols are only required for the activation at the membrane of some substrates including AKT. PDPK1 however does not require membrane lipid binding for the efficient phosphorylation of most of its substrates in the cytosol.PDK1 is implicated in the development and progression of melanomas.[5]Many cancer-driving mutations induce activation of PDK1 targets including Akt, S6K (p70 ribosomalS6 kinase) and SGK (serum- and glucocorticoid-induced protein kinase).

GSK2334470 is more effective at inhibiting PDK1 substrates that are activated in the cytosol rather than at the plasma membrane. Consistent with this, GSK2334470 inhibited Akt activation in knock-in embryonic stem cells expressing a mutant of PDK1 that is unable to interact with phosphoinositides more potently than in wild-type cells by Immunoblotting.[6]GSK2334470 also suppressed T-loop phosphorylation and activation of RSK2 (p90 ribosomal S6 kinase 2), another PDK1 target activated by the ERK(extracellular-signal-regulated kinase) pathway.[7] GSK2334470 will be useful in probing biological processes controlled by PDK1. Therefore, GSK2334470 is much more specific than other reported PDK1 inhibitors.

特別提醒：

1. 本產(chǎn)品僅供科研使用。請(qǐng)勿用于醫(yī)藥、臨床診斷或治療，食品及化妝品等用途。請(qǐng)勿存放于普通住宅區(qū)。

2. 為了您的安全和健康，請(qǐng)穿好實(shí)驗(yàn)服并佩戴一次性手套和口罩操作。

原創(chuàng)作者：上海莼試生物技術(shù)有限公司

在線(xiàn)咨詢(xún)

留言注意事項(xiàng)：

1.遵守中華人民共和國(guó)有關(guān)法律、法規(guī)，尊重網(wǎng)上道德，承擔(dān)一切因您的行為而直接或間接引起的法律責(zé)任。

2.請(qǐng)您真實(shí)的反映產(chǎn)品的情況,不要捏造、誣蔑、造謠。如對(duì)產(chǎn)品有任何疑問(wèn),也可以留言咨詢(xún)。

3.未經(jīng)本站同意，任何人不得利用本留言簿發(fā)布個(gè)人或團(tuán)體的具有廣告性質(zhì)的信息或類(lèi)似言論。

您感興趣的產(chǎn)品*
您的單位*
聯(lián)系人*
聯(lián)系電話(huà)*
詳細(xì)地址*
常用郵箱*
請(qǐng)輸入您對(duì)我們的意見(jiàn)或建議*
驗(yàn)證碼*